0.4588
price down icon9.76%   -0.0496
after-market After Hours: .49 0.0312 +6.80%
loading

Applied Therapeutics Inc Stock (APLT) Forecast

The Applied Therapeutics Inc (APLT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $24.06, representing a +5,145% increase from the current price of $0.4588. The highest analyst price target is $34.74, and the lowest is $13.39.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month APLT Price Target
Average 27.98 (+6,000% Upside)
loading

Is Applied Therapeutics Inc (APLT) A Buy Now?

Oscillators
Name Value Action
RSI(14) 26.29 Buy
STOCH(9,6) 13.96 Buy
STOCHRSI(14) 15.34 Buy
MACD(12,26) -0.1211 Buy
ADX(14) 32.05 Sell
William %R -98.68 Buy
CCI(14) -143.70 Sell
Buy: 5 Sell: 2 Neutral: 0
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
0.5331
Sell
0.5256
Sell
MA20
0.5618
Sell
0.5781
Sell
MA50
0.6811
Sell
1.3175
Sell
MA100
3.9366
Sell
2.7083
Sell
MA200
4.7369
Sell
3.7326
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, APLT could be considered a Strong Sell, with 17 technical analysis indicators signaling 5 Buy signals, 12 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on APLT, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 26.29 indicates that APLT is oversold. This indicates that APLT price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
  2. STOCH (Stochastic Oscillator): The STOCH value of 13.96 indicates that APLT is oversold. This indicates that APLT price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 15.34 indicates that APLT is oversold. This suggests that APLT price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 32.05 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -143.7 indicates that APLT is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term APLT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Applied Therapeutics Inc financial reports and earnings history, Applied Therapeutics Inc (APLT) stock could reach $2.1667 by 2030, $7.5949 by 2040 and $16.70 by 2050. See the projected annual prices until 2050 of the Applied Therapeutics Inc stock below:

  • Applied Therapeutics Inc (APLT) is expected to reach an average price of $3.0766 in 2035, with a high prediction of $3.4291 and a low estimate of $3.4026. This indicates an $570.58% rise from the last recorded price of $0.4588.
  • Applied Therapeutics Inc (APLT) stock is projected to chart a bullish course in 2040, with an average price target of $7.8049, representing an $1,601% surge from its current level. The forecast ranges from a conservative $7.9085 to a sky-high $7.5949.
  • Our analysts predict Applied Therapeutics Inc (APLT) to jump 2,728% by 2045, soaring from $13.05 to an average price of $12.98, potentially reaching $13.18. While $13.05 is the low estimate, the potential upside is significant.
  • Applied Therapeutics Inc (APLT) stock is expected to climb by 2050, reaching an average of $16.83, a $3,567% jump from its current level. However, a wide range of estimates exists, with high and low targets of $16.70 and $16.64, respectively, highlighting the market's uncertainty.

Applied Therapeutics Inc Stock (APLT) Year by Year Forecast

Applied Therapeutics Inc Stock (APLT) Price Forecast for 2025

Applied Therapeutics Inc Stock (APLT) is expected to reach an average price of $31.59 in 2025, with a high prediction of $52.26 and a low estimate of $10.93. This indicates an +6,786% rise from the last recorded price of $0.4588.
Month Average Low High Change from today's price
April, 2025 $26.45 $13.39 $34.74 +5,665%
May, 2025 $30.75 $27.47 $42.97 +6,603%
June, 2025 $42.58 $29.62 $46.68 +9,180%
July, 2025 $30.44 $29.48 $47.05 +6,534%
August, 2025 $23.50 $21.72 $32.32 +5,022%
September, 2025 $24.41 $19.03 $28.52 +5,220%
October, 2025 $19.50 $17.53 $23.97 +4,149%
November, 2025 $15.30 $14.07 $22.44 +3,235%
December, 2025 $11.83 $10.93 $19.79 +2,479%

Applied Therapeutics Inc Stock (APLT) Price Forecast for 2026

The predicted value for Applied Therapeutics Inc (APLT) in 2026 is set at an average of $17.10. Estimates vary from a peak of $25.29 to a trough of $8.9024, indicating an +3,626% surge from the present price of $0.4588.
Month Average Low High Change from today's price
January, 2026 $18.66 $8.9227 $19.90 +3,968%
February, 2026 $17.72 $14.68 $21.90 +3,762%
March, 2026 $15.19 $14.78 $19.59 +3,211%
April, 2026 $17.23 $14.98 $25.29 +3,656%
May, 2026 $15.40 $11.77 $18.32 +3,258%
June, 2026 $11.99 $11.69 $15.72 +2,513%
July, 2026 $12.76 $9.3502 $15.22 +2,681%
August, 2026 $18.13 $12.37 $20.11 +3,852%
September, 2026 $15.35 $14.83 $21.29 +3,245%
October, 2026 $11.85 $10.96 $16.70 +2,482%
November, 2026 $11.75 $9.4793 $14.81 +2,461%
December, 2026 $13.54 $8.9024 $13.66 +2,852%

Applied Therapeutics Inc Stock (APLT) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Applied Therapeutics Inc (APLT) is $7.5687, with a high forecast of $15.04 and a low forecast of $0.0926. This indicates an +1,550% increase from the last price of $0.4588.
Month Average Low High Change from today's price
January, 2027 $10.66 $9.3254 $15.04 +2,223%
February, 2027 $6.8484 $6.1884 $12.34 +1,393%
March, 2027 $5.8614 $4.7708 $7.8596 +1,178%
April, 2027 $0.7661 $0.0926 $5.942 +66.99%
May, 2027 $1.5637 $1.2655 $1.0937 +240.83%
June, 2027 $2.2507 $1.7831 $1.9707 +390.56%
July, 2027 $1.5183 $1.6483 $1.7701 +230.92%
August, 2027 $1.7858 $1.4877 $1.6958 +289.24%
September, 2027 $2.2628 $1.9952 $2.1334 +393.20%
October, 2027 $2.8151 $2.5121 $2.4604 +513.58%
November, 2027 $2.588 $2.7171 $2.6993 +464.07%
December, 2027 $2.0849 $2.2949 $2.5429 +354.43%

Applied Therapeutics Inc Stock (APLT) Price Forecast for 2028

In 2028, Applied Therapeutics Inc (APLT) is projected to reach an average price of $2.2205, with a high projection of $2.7715 and a low estimate of $1.6695. This indicates an +383.98% rise from the last price of $0.4588.
Month Average Low High Change from today's price
January, 2028 $2.0625 $2.2137 $2.1131 +349.55%
February, 2028 $2.86 $2.1819 $2.4709 +523.37%
March, 2028 $2.7002 $2.7078 $2.7715 +488.53%
April, 2028 $2.2647 $2.5347 $2.5265 +393.60%
May, 2028 $2.5716 $2.499 $2.5016 +460.51%
June, 2028 $2.0792 $2.2592 $2.371 +353.18%
July, 2028 $2.2268 $2.1979 $2.1174 +385.35%
August, 2028 $2.2416 $2.2645 $2.2338 +388.57%
September, 2028 $2.3153 $2.3905 $2.3125 +404.65%
October, 2028 $1.5189 $1.6695 $2.1508 +231.06%
November, 2028 $1.5959 $1.7183 $1.7056 +247.84%
December, 2028 $1.6535 $1.6747 $1.6235 +260.39%

Applied Therapeutics Inc Stock (APLT) Price Forecast for 2029

The 2029 price forecast for Applied Therapeutics Inc Stock (APLT) is $3.3959 on average, with a high prediction of $6.7902 and a low estimate of $0.00166. This represents an +640.17% increase from the previous price of $0.4588.
Month Average Low High Change from today's price
January, 2029 $1.1804 $1.3161 $1.5649 +157.29%
February, 2029 $1.588 $1.537 $1.478 +246.12%
March, 2029 $0.1756 $1.0356 $1.5673 -61.73%
April, 2029 $0.3332 $0.5032 $0.3038 -27.38%
May, 2029 $0.7901 $0.3834 $0.5401 +72.22%
June, 2029 $0.3723 $0.5177 $0.6595 -18.86%
July, 2029 $0.4453 $0.0471 $1.7247 -2.94%
August, 2029 $0.3777 $0.1534 $0.5671 -17.67%
September, 2029 $4.5202 $0.00166 $6.7902 +885.21%
October, 2029 $4.2532 $2.792 $5.1278 +827.02%
November, 2029 $1.7756 $1.6606 $4.1638 +287.01%
December, 2029 $1.1288 $1.4488 $2.1968 +146.03%

Applied Therapeutics Inc Stock (APLT) Price Forecast for 2030

Applied Therapeutics Inc Stock (APLT) is expected to reach an average price of $23.86 in 2030, with a high forecast of $47.12 and a low forecast of $0.5909. This signifies an +5,100% surge from the last price of $0.4588.
Month Average Low High Change from today's price
January, 2030 $2.7927 $1.3676 $2.1667 +508.70%
February, 2030 $2.1979 $2.3879 $2.1625 +379.05%
March, 2030 $1.123 $2.3104 $1.5855 +144.78%
April, 2030 $1.4332 $1.3206 $0.8318 +212.38%
May, 2030 $0.0279 $0.7521 $0.7942 -93.93%
June, 2030 $6.3827 $0.5909 $9.8303 +1,291%
July, 2030 $10.79 $3.4951 $15.72 +2,252%
August, 2030 $16.85 $8.04 $18.33 +3,573%
September, 2030 $38.07 $13.65 $42.85 +8,197%
October, 2030 $29.81 $27.81 $47.12 +6,397%
November, 2030 $20.37 $8.3181 $34.60 +4,340%
December, 2030 $32.96 $18.50 $37.94 +7,085%
$76.29
price down icon 6.45%
$22.96
price up icon 1.23%
$33.86
price up icon 0.65%
$19.13
price down icon 7.54%
biotechnology ONC
$245.53
price down icon 9.67%
$111.56
price down icon 1.20%
Cap:     |  Volume (24h):